Sanket Shah

Sanket Shah, MBBS, PhD, currently serves as the Director of Global Value & HEOR at Jazz Pharmaceuticals, focusing on market access planning and value enhancement for late-stage asset commercialization. As an angel investor since July 2021, Sanket also contributes as a peer reviewer for the Journal of Managed Care and Specialty Pharmacy. Previously, Sanket held several leadership roles in HEOR strategy at Novo Nordisk, specializing in rare diseases, and was an active member of the ISPOR Steering Committee for the New Professionals Network. Sanket's early career included research and teaching positions at The University of Texas at Austin and internships in HEOR with AbbVie. Educational qualifications include a PhD in Health Outcomes and Pharmacy Practice along with an MBBS from Maharashtra University of Health Sciences.